SAO:ONCO3

Oncoclínicas do Brasil Serviços Médicos S.A. · SAO · Healthcare · BRL · FY for 2025

Figures on this page computed 2026-11-08 13:27 UTC

Last close

n/aBRL

Market data

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
BRL
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
-63.1%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
-5.0%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
4.22Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
BRL
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
BRL
- computed

Safety is the furthest below its sector's middle: 0.11 against 0.58 on the market's range.

Follow one real

lens 1 of 9

After what it costs to make

31.1%

After running the business

-43.0%

After interest and tax

-63.1%

After what it must reinvest

-5%

Kept after the dividend

-5.6%

after what it costs to make, 31.1% of sales; after running the business, -43.0% of sales; after interest and tax, -63.1% of sales; after what it must reinvest, -5.0% of sales; kept after the dividend, -5.6% of sales

The five stops

5 of 5 read

After what it costs to make1,786,301,00031.1%
After running the business-2,466,519,000-43.0%
After interest and tax-3,623,788,000-63.1%
After what it must reinvest-286,745,000-5%
Kept after the dividend-323,521,000-5.6%

Of every unit of sales, -0.06 is still there after the dividend.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales5,739,367,000
Source
computed
Statement
income
Fiscal year
2025
Reported in
BRL
After what it costs to make1,786,301,000
Source
computed
Statement
income
Fiscal year
2025
Reported in
BRL
After running the business-2,466,519,000
Source
computed
Statement
income
Fiscal year
2025
Reported in
BRL
After interest and tax-3,623,788,000
Source
computed
Statement
income
Fiscal year
2025
Reported in
BRL
After what it must reinvest-286,745,000
Source
computed
Statement
income
Fiscal year
2025
Reported in
BRL
Kept after the dividend-323,521,000
Source
computed
Statement
income
Fiscal year
2025
Reported in
BRL